Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Key Points

  • Disease summary:

    • Metabolic syndrome (MetS) is a complex genetic disorder, involving the interaction of multiple genetic loci with environmental factors.

    • MetS consists of three of the five following criteria: increased waist circumference (Table 12-1); triglyceride (TG) level greater than or equal to 150 mg/dL (1.7 mmol/L) or drug treatment for elevated TG; high-density lipoprotein-cholesterol (HDL-C) less than 40 mg/dL (1 mmol/L) in males or less than 50 mg/dL (1.3 mmol/L) in females or drug treatment for reduced HDL-C level; systolic blood pressure (SBP) greater than or equal to 130 mm Hg and/or diastolic blood pressure (DBP) greater than or equal to 85 mm Hg or antihypertensive drug treatment in a patient with a history of elevated blood pressure (BP); fasting glucose greater than or equal to 100 mg/dL (5.6 mmol/L) or drug treatment for elevated glucose.

    • Individuals with MetS have a twofold increased risk for cardiovascular disease (CVD) and fivefold increased risk for type 2 diabetes (DM2) compared to individuals without MetS.

  • Differential diagnosis:

    • MetS is polygenic in nature and may be often evident in individuals with coexistent DM2, HIV lipodystrophy, or polycystic ovary syndrome. Rare monogenic forms of lipodystrophy such as familial partial lipodystrophy (FPLD), congenital generalized lipodystrophy (CGL), and acquired partial lipodystrophy (APL) are often considered extreme forms of MetS.

  • Monogenic forms:

    • Extreme forms of MetS may be evident in monogenic forms of lipodystrophy such as FPLD, CGL, and APL.

  • Family history:

    • There may be a family history of one or more of the components of MetS. In the genetic lipodystrophies with MetS phenotype, FPLD is inherited in an autosomal dominant fashion, while CGL is inherited as an autosomal recessive trait.

  • Environmental factors:

    • The components of MetS may be exacerbated by environmental factors. For example, hypertension can be aggravated by excessive salt. Dietary components such as intake of saturated fat or simple carbohydrates can influence the onset and severity of dysglycemia and dyslipidemia. Overall, obesity is a significant moderator of all components of MetS.

  • Genome-wide association studies:

    • Many associations have been reported for common MetS, especially its individual components. There is no evidence at present for any added diagnostic, prognostic, or therapeutic value of genetic evaluation for common single-nucleotide polymorphism (SNP) genotypes or risk allele scores for the component quantitative traits in common MetS presentation.

  • Pharmacogenomics:

    • There is no demonstration yet of a potential role for pharmacogenetic evaluation in common MetS. FPLD2 (due to mutant LMNA) appears to be more responsive to therapy with thiazolidinediones than is FPLD3 (due to mutant PPARG).

Diagnostic Criteria and Clinical Characteristics

Diagnostic Criteria for Metabolic Syndrome

Although several different definitions for MetS have been proposed, six different organizations have recently issued a joint statement in an attempt to harmonize the definition of MetS. According to their report, ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.